ALGN vs HSIC vs NVST Stock Comparison

Align Technology, Henry Schein and Envista Holdings Prices as of Nov 13, 2026 Peers: Industry group
ALGN Align Technology Inc
$168.32 +16.5% 1M +20.7% 1Y
Market cap
$11.81B
P/E
24.0x
Revenue (TTM)
$4.16B
Div. yield
–
Dental Healthcare
1 win
HSIC Henry Schein Inc
$86.22 +0.8% 1M +17.6% 1Y
Market cap
$9.41B
P/E
22.4x
Revenue (TTM)
$13.73B
Div. yield
–
Drug Distribution Healthcare
3 wins

Head to Head

11 decided of 12

Envista Holdings leads on 7 of the 12 questions below (Envista Holdings 7, Henry Schein 3, Align Technology 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionALGNHSICNVSTLeader
Larger companyMarket capitalisation $11.81B $9.41B $3.87B ALGN
Cheaper on earningsLower P/E, profitable companies only 24.0x 22.4x 6.1x NVST
Cheaper on forward earningsLower price / next fiscal year consensus EPS 15.5x 14.6x 16.0x HSIC
Faster revenue growthRevenue growth, trailing twelve months +4.4% +6.2% +9.8% NVST
More profitableNet margin, trailing twelve months 11.8% 3.1% 22.0% NVST
Better return on capitalReturn on invested capital — 7.3% 15.0% NVST
Less leveragedLower net debt / EBITDA — 3.2x 0.3x NVST
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +20.7% +17.6% +23.2% NVST
Better 5-year returnAnnualised price return, 5 years -24.6%/yr +1.7%/yr -10.8%/yr HSIC
Less volatileAnnualised volatility, 1 year 40.3% 25.2% 40.7% HSIC
Higher overall scoreMean of the five percentile scores vs peers 70/100 57/100 81/100 NVST

Percentile Scorecard

ALGNHSICNVST

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisALGNHSICNVST
Valuation 85 #37 of 243 46 #15 of 27 98 #7 of 243
Growth 38 #142 of 228 48 #14 of 26 74 #60 of 228
Profitability 87 #29 of 222 76 #7 of 26 86 #31 of 222
Financial Health 48 #130 of 248 20 #21 of 26 50 #125 of 248
Shareholder Returns 92 #13 of 158 94 #2 of 18 98 #5 of 158
Overall 70 57 81
  • ALGN ranked among 252 companies in Medical Devices and Diagnostics
  • HSIC ranked among 27 companies in Healthcare Payers and Distributors
  • NVST ranked among 252 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodALGNHSICNVSTSPY
1 month +16.5%+0.8%+7.3% -2.0%
3 months -7.2%-4.0%-12.7% -2.8%
6 months +7.0%+18.6%+5.5% +2.0%
Year to date +7.8%+14.1%+12.9% +10.6%
1 year +20.7%+17.6%+23.2% +12.2%
3 years -17.0%+25.1%+9.6% +68.1%
3 years, per year -6.0%+7.8%+3.1% +18.9%
5 years -75.5%+8.8%-43.4% +61.4%
5 years, per year -24.6%+1.7%-10.8% +10.1%
10 years +83.9%+40.3%— +248.5%
10 years, per year +6.3%+3.4%— +13.3%

Risk

MeasureALGNHSICNVSTSPY
Volatility, 1Y 40.3%25.2%40.7% 13.6%
Downside volatility, 1Y 37.6%25.4%37.3% 13.9%
Beta vs S&P 500, 1Y 1.330.631.31 1.00
Return / volatility, 1Y 0.510.700.57 0.90
Max drawdown, 5Y -82.0%-32.7%-71.0% -25.4%
From 52-week high -14.8%-5.1%-19.0% -3.2%
52-week high $197.51$90.86$30.26 $779.14
52-week low $132.28$68.99$18.95 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleALGNHSICNVST
P/E now vs peer median 24.3xmedian 26.5x 22.8xmedian 25.2x 6.2xmedian 26.5x
P/S now vs peer median 2.9xmedian 2.7x 0.7xmedian 0.4x 1.4xmedian 2.7x
EV/EBITDA now vs peer median 12.5xmedian 18.4x 12.4xmedian 14.5x 5.0xmedian 18.4x
P/FCF now vs peer median 19.7xmedian 25.4x 17.0xmedian 16.5x 16.2xmedian 25.4x
P/B now vs peer median 2.8xmedian 2.5x 2.5xmedian 2.7x 1.3xmedian 2.5x
PEG now vs peer median 1.78median 0.98 6.74median 1.72 0.12median 0.98

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsALGNHSICNVST
Revenue $4.16B $13.73B $2.88B
Gross profit $2.88B $4.34B $1.61B
Operating income $620.46M $709.00M $731.30M
Net income $491.87M $443.00M $633.60M
Free cash flow $602.50M $559.00M $242.00M
R&D $377.60M – $121.80M
EPS (diluted) $6.93 $3.74 $3.88
Cash & equivalents $1.14B $184.00M $1.16B
Total debt – $3.52B $1.43B
Shares (diluted) 71.02M 112.54M 163.40M
Enterprise value $7.58B $9.23B -$706.84M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricALGNHSICNVST
P/E 24.3x 22.8x 6.2x
P/FCF 19.7x 17.0x 16.2x
P/Operating cash flow 15.9x 13.9x 13.0x
P/S 2.9x 0.7x 1.4x
P/B 2.8x 2.5x 1.3x
P/Tangible book 2.8x 3.3x 1.6x
EV/EBITDA 12.5x 12.4x 5.0x
EV/EBIT 17.3x 18.2x 5.7x
EV/Revenue 2.6x 0.9x 1.5x
EV/FCF 17.8x 23.0x 17.3x
EV/Operating cash flow 14.3x 18.7x 13.9x
PEG (3Y EPS CAGR) 1.78 6.74 0.12

Growth

14 metrics
MetricALGNHSICNVST
Revenue growth (1Y) 4.4% 6.2% 9.8%
Revenue CAGR (3Y) 3.0% 2.7% 3.7%
Gross profit growth (1Y) 5.5% 7.5% 11.0%
Gross profit CAGR (3Y) 2.7% 3.3% 3.0%
Operating income growth (1Y) 16.1% 9.9% 287.1%
Operating income CAGR (3Y) 2.0% 3.0% 31.4%
Net income growth (1Y) 30.0% 7.5% 4,041%
Net income CAGR (3Y) 10.7% -2.0% 49.2%
EPS growth (1Y) 32.6% 15.8% 4,110%
EPS CAGR (3Y) 13.6% 3.4% 52.7%
Operating cash flow growth (1Y) 14.3% 28.4% 0.6%
Operating cash flow CAGR (3Y) -5.3% -4.4% 2.0%
Free cash flow growth (1Y) 6.3% 38.7% -7.8%
Free cash flow CAGR (3Y) -4.2% -4.9% 3.7%

Profitability

14 metrics
MetricALGNHSICNVST
Gross margin 69.1% 31.6% 55.9%
EBITDA margin 20.6% 7.6% 29.3%
Operating margin 14.9% 5.2% 25.4%
Pretax margin 15.5% 4.2% 23.8%
Net margin 11.8% 3.1% 22.0%
FCF margin 14.5% 4.1% 8.4%
Operating cash flow margin 18.0% 5.0% 10.5%
Return on equity 11.5% 11.6% 20.6%
Return on assets 7.6% 3.9% 11.3%
Return on invested capital – 7.3% 15.0%
Return on capital employed 13.6% 9.0% 15.3%
Asset turnover 0.6x 1.2x 0.5x
Cash conversion (OCF / net income) 1.5x 1.6x 0.5x
Stock comp / revenue 4.1% 0.3% 1.4%

Financial Health

11 metrics
MetricALGNHSICNVST
Debt / assets – 30.6% 25.5%
Debt / equity – 0.9x 0.5x
Net debt / EBITDA – 3.2x 0.3x
Debt / FCF – 6.3x 5.9x
Liabilities / assets 34.0% 66.8% 45.0%
Equity / assets 66.0% 33.2% 55.0%
Interest coverage – 4.3x –
Current ratio 1.4x 1.3x 2.5x
Quick ratio 1.2x 0.6x 2.0x
Cash ratio 0.6x 0.1x 1.4x
Altman Z-score 4.89 2.65 2.17

Shareholder Returns

7 metrics
MetricALGNHSICNVST
Dividend yield – – –
Net buyback yield 2.3% 6.8% 3.4%
Shareholder yield 2.3% 6.8% 3.4%
Payout ratio (earnings) – 6.8% –
Payout ratio (FCF) – 5.4% –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusALGNHSICNVST
Forward P/E 15.5xFY2026 14.6xFY2026 16.0xFY2026
EPS, next fiscal year $10.86FY2026 $5.89FY2026 $1.53FY2026
EPS growth, next FY +3.3%FY2026 +18.5%FY2026 +28.6%FY2026
EPS growth, the year after +16.6% +5.9% +15.0%
Revenue, next fiscal year $3.84BFY2026 $13.36BFY2026 $2.98BFY2026
Revenue growth, next FY -4.7%FY2026 +1.3%FY2026 +9.4%FY2026
Revenue growth, the year after +3.1% +4.6% +2.6%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersALGNHSICNVST
Held by institutions 100.0% 100.0% 100.0%
Institutions holding 678 566 382
Change in shares held, QoQ +4.2% +2.1% +6.4%
Institutions buying 293 244 200
Institutions selling 268 217 129
Buyers to sellers 1.09 1.12 1.55

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

ALGNHSICNVST
ALGN 1.00 0.56 0.71
HSIC 0.56 1.00 0.67
NVST 0.71 0.67 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, ALGN, HSIC and NVST?

Align Technology (ALGN) is the largest by market capitalisation: Align Technology (ALGN) $11.81B, Henry Schein (HSIC) $9.41B, Envista Holdings (NVST) $3.87B.

Which stock is cheaper, ALGN, HSIC and NVST?

Envista Holdings (NVST) trades on the lowest price-to-earnings ratio (Align Technology (ALGN) 24.0x, Henry Schein (HSIC) 22.4x, Envista Holdings (NVST) 6.1x). On next year's consensus earnings, Henry Schein (HSIC) is cheapest (Align Technology (ALGN) 15.5x, Henry Schein (HSIC) 14.6x, Envista Holdings (NVST) 16.0x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Envista Holdings (NVST) grew revenue fastest over the trailing twelve months: Align Technology (ALGN) +4.4%, Henry Schein (HSIC) +6.2%, Envista Holdings (NVST) +9.8%.

Which company is more profitable?

Envista Holdings (NVST) has the highest net margin (Align Technology (ALGN) 11.8%, Henry Schein (HSIC) 3.1%, Envista Holdings (NVST) 22.0%). On return on invested capital, Envista Holdings (NVST) leads (Henry Schein (HSIC) 7.3%, Envista Holdings (NVST) 15.0%).

Which stock has performed better?

Over the past year Envista Holdings (NVST) returned the most: Align Technology (ALGN) +20.7%, Henry Schein (HSIC) +17.6%, Envista Holdings (NVST) +23.2%. Over five years, Henry Schein (HSIC) compounded fastest (Align Technology (ALGN) -24.6%/yr, Henry Schein (HSIC) +1.7%/yr, Envista Holdings (NVST) -10.8%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Henry Schein (HSIC) has been the steadiest (Align Technology (ALGN) 40.3%, Henry Schein (HSIC) 25.2%, Envista Holdings (NVST) 40.7%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, ALGN, HSIC and NVST?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Envista Holdings (NVST) leads on 7. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.